StockData

Drugs, Drug Proprietaries, and Druggists' Sundries stocks

The 11 US-listed companies classified as drugs, drug proprietaries, and druggists' sundries (SIC group 512), largest first.

Prices as of Oct 30, 2026
Market value
$239.02B
11 companies
Year to date
+13.9%
On the day +0.64%
Over 52 weeks
+15.2%
Weighted by market value
P/E
27.3×
Net margin 0.9%

Drugs, Drug Proprietaries, and Druggists' Sundries companies

Ranked by market cap at the latest close. Revenue, margin and P/E use the last twelve months.

#CompanyMarket capPrice1DYTD1YRevenueNet marginP/E
1mckMcKesson$115.96B$994.58+1.40%+21.25%+20.48%$410.98B1.1%25.3×
2corCencora$63.13B$330.84+0.09%−2.05%−3.04%$332.77B0.8%24.1×
3cahCardinal Health$58.26B$250.48−0.24%+21.89%+31.94%$254.25B0.7%34.0×
4hlfHerbalife$1.37B$13.05+0.93%+1.24%+68.39%$5.20B3.2%8.3×
5nusNu Skin Enterprises$226.35M$4.65−0.85%−51.66%−56.21%$1.38B-15.7%–
6hkpdCellyan Biotechnology$32.37M$1.98−9.59%+140.2%−92.14%–––
7cosmCosmos Health$28.18M$0.28+12.00%−43.78%−69.77%$73.73M-33.1%–
8esynHWH International$13.52M$1.75−4.37%+17.45%−9.79%$389.74K-680.0%–
9medsDataMeds AI$5.88M$1.92−5.42%−90.39%−95.12%$8.02M-1100.3%–
10stekStemtech$299.70K$0.00010.00%−87.50%−98.00%$2.40M-159.7%–
11nascCan B–$0.015−1.32%−7.02%−25.00%–––

Compare companies in the screener or browse all industries.